Jun 02, 2023 / 08:00PM GMT
Presentation
Jun 02, 2023 / 08:00PM GMT
=====================
Corporate Participants
=====================
* Christian Martin Itin
Autolus Therapeutics plc - CEO & Director
* Julia Wilson
=====================
Conference Call Participants
=====================
* Asthika Sarith Goonewardene
Truist Securities, Inc., Research Division - Research Analyst
* Dingding Shi
Jefferies LLC, Research Division - Equity Analyst
* Eric William Joseph
JPMorgan Chase & Co, Research Division - VP & Senior Analyst
* Gil Joseph Blum
Needham & Company, LLC, Research Division - Senior Analyst
* Mara Goldstein
Mizuho Securities USA LLC, Research Division - MD of Equity Research Department
* Matthew Christopher Phipps
William Blair & Company L.L.C., Research Division - Senior Biotechnology Research Analyst
* Rajan Sharma
Goldman Sachs Group, Inc., Research Division - Research Analyst
* Yanan Zhu
Wells Fargo Securities, LLC, Research Division
Autolus Therapeutics PLC
(NAS:AUTL)
$
1.52
+0.060 (+4.14%)
Market Cap: 404.54 Mil
Enterprise Value: 252.40 Mil
PE Ratio: 0
PB Ratio: 3.68
GF Score: 68/100 Autolus Therapeutics PLC ASCO Oral Presentation Transcript
Jun 02, 2023 / 08:00PM GMT
Release Date Price:
$2.9
(-7.35%)
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot